Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture
NCT ID: NCT07086872
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2025-07-30
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Adding Integrated Neuromuscular Inhibition Technique to Postural Correction Exercises in Patients With Cervicogenic Headache
NCT07086898
Effect of Integrated Neuromuscular Inhibition Technique on Subjects with Neck Pain and Forward Head Posture
NCT05439018
Muscle Energy Technique Versus Mulligan Mobilization on Forward Head Posture
NCT06732557
Impact of Adding Jones Technique to Mulligan Therapy in Patients With Cervicogenic Headache
NCT07047313
Effect of Muscle Energy Technique on Craniovertebral and Shoulder Angles in Forward Head Posture
NCT05642130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Neuromuscular Inhibition Technique and mulligan therapy
thirty patients will receive Integrated Neuromuscular Inhibition Technique and mulligan therapy three times a weeks for six weeks+postural correction exercises
Integrated Neuromuscular Inhibition Technique and mulligan therapy
patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique and mulligan therapy for limited cervical range of motion
postural correction exercises
the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall
Integrated Neuromuscular Inhibition Technique
thirty patients will receive Integrated Neuromuscular Inhibition Technique+postural correction exercises three times a weeks for six weeks
Integrated Neuromuscular Inhibition Technique
patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique
postural correction exercises
the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall
mulligan therapy
thirty patients will receive mulligan Technique+postural correction exercises three times a weeks for six weeks
mulligan therapy
patients will receive mulligan therapy for limited cervical range of motion
postural correction exercises
the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall
postural correction exercises
thirty patients will receive postural correction exercises three times a weeks for six weeks
postural correction exercises
the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated Neuromuscular Inhibition Technique and mulligan therapy
patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique and mulligan therapy for limited cervical range of motion
Integrated Neuromuscular Inhibition Technique
patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique
mulligan therapy
patients will receive mulligan therapy for limited cervical range of motion
postural correction exercises
the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Had cervical pain for more than three months and had visited an orthopedist clinic
Exclusion Criteria
* fractures or cervical spinal surgery
* Cervical or shoulder neurological movement disorder.
* Temporo-mandibular surgery, (5) Pathologic trauma
18 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Al Shaymaa Shaaban Abd El Azeim
principle investigator : alshaymaa shaaban abd el azeim
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005806
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.